Next 10 |
(NewsDirect) A U.S.-based medical device company recently completed its successful uplisting to the New York Stock Exchange (NYSE) American exchange. Know Labs Inc. (NYSEAMERICAN: KNW) raised over $8 million from its public offering of common stock. Know Labs announc...
(NewsDirect) It’s fairly common knowledge that our data is being used to learn and predict human behavior, often to the benefit of the companies who aggregate and analyze this data. But can these diverse data sets be applied within healthcare to help drive innovation and improve ...
Know Labs ( OTCQB:KNWN ) announces that its common stock has been approved for listing on the NYSE American stock exchange, in conjunction with an underwritten public offering of the company's common stock. Trading will commence on NYSE American, the ticker symb...
Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price requirement) at the time of listing, the Company has been approved to uplist to ...
Know Labs, Inc. (OTCQB: KNWN) , an emerging developer of non-invasive medical diagnostic technology, today released a video update on the IRB-approved internal trial the Company has been conducting at its laboratory in Seattle. The video can be found here . The two-minute vi...
--News Direct-- Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds to that pain and inconvenience. But new developments from compani...
Know Labs ( OTCQB:KNWN ) on Wednesday has proposed a new stock offering of 3M shares priced at $2 each, as per the Form S-1 registration statement. The medical diagnostic technology company said it will apply to uplist its shares to the NYSE under the proposed new ticker symbo...
Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed new offering of 3 million shares of its common stock with an anticipated offering price of $2.00 per share...
Know Labs has filed proposed terms for a $6 million U.S. IPO uplisting. The firm is developing a non-invasive blood glucose monitoring device and vital signs monitoring system. KNW is still in development for its devices. While the low nominal per share price may attract day trade...
Know Labs, Inc. (OTCQB: KNWN) , an emerging leader in non-invasive medical diagnostic technology, today announced the addition of two senior executives, each of whom will play a pivotal role in guiding the company toward its goal of delivering the first FDA-cleared non-invasive gluc...
News, Short Squeeze, Breakout and More Instantly...
Know Labs Inc Company Name:
KNWN Stock Symbol:
OTCMKTS Market:
(NewsDirect) A U.S.-based medical device company recently completed its successful uplisting to the New York Stock Exchange (NYSE) American exchange. Know Labs Inc. (NYSEAMERICAN: KNW) raised over $8 million from its public offering of common stock. Know Labs announc...
(NewsDirect) It’s fairly common knowledge that our data is being used to learn and predict human behavior, often to the benefit of the companies who aggregate and analyze this data. But can these diverse data sets be applied within healthcare to help drive innovation and improve ...
Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price requirement) at the time of listing, the Company has been approved to uplist to ...